Rectal cell-associated HIV-1 RNA: A new marker ready for the clinic

HIV Clinical Trials

Volumn 10, Issue 5, 2009, Pages 324-327

  Lafeuillade, Alain ^a   Cheret, Antoine ^a   Hittinger, Gilles ^a   Bernardini, David ^a   Cuquemelle, Caroline ^a   Jullian, Eric ^a   Poggi, Cécile ^a  

^a GENERAL HOSPITAL   (France)

Author keywords

Eradication; Gut; HIV; Reservoir

Indexed keywords

BIOLOGICAL MARKER; PROTEINASE INHIBITOR; RECTAL CELL ASSOCIATED HIV 1 RNA; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; PRIORITY JOURNAL; RECTUM BIOPSY; RNA ANALYSIS; VIREMIA; VIRUS LOAD;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOLOGICAL MARKERS; DISEASE RESERVOIRS; DNA, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; LABORATORIES, HOSPITAL; LIMIT OF DETECTION; LYMPHOID TISSUE; MIDDLE AGED; PILOT PROJECTS; RECTUM; RNA, VIRAL;

EID: 70450219144     PISSN: 15284336     EISSN: None     Source Type: Journal    
DOI: 10.1310/hct1005-324     Document Type: Article

References (9)

1. Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, Roederer M. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature. 2005;434:1093-1097.
2. Guadalupe M, Sankaran S, George MD, et al. Viral suppression and immune restoration in the gastrointestinal mucosa of human immunoDeficiency virus type 1-infected patients initiating therapy during primary or chronic infection. J Virol. 2006;80: 8236-8247.
3. Chun TW, Nickle DC, Justement JS, et al. Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. J Infect Dis. 2008;197:714-720.
4. Avettand-Fenoel V, Prazuck T, Hocqueloux L, et al. HIVDNA in rectal cells is well correlated with HIV-DNA in blood in different groups of patients, including long-term non-progressors. AIDS. 2008;22(14):1880-1882.
5. Dinoso JB, Kim SY, Wiegand AM, et al. Treatment intensifi cation does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy. Proc Natl Acad Sci USA. 2009;106(23):9403-9408.
6. Médecine - Sciences Flammarion, Ed. Rapport Yéni 2008. Prise en charge médicale des personnes infectées par le VIH-1. Recommandations du groupe d'experts. pp. 322-323. ISBN 978-2-2570-0062-0.
7. Palmer S, Wiegand AP, Maldarelli F, et al. New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunoDeficiency virus type 1 RNA in plasma. J Clin Microbiol. 2003;41:4531-4536.
8. Shen L, Siliciano RF. Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection. J Allergy Clin Immunol. 2008;122(1):22-28.
9. Poles MA, Boscardin WJ, Elliott J, et al. Lack of decay of HIV-1 in gut-associated lymphoid tissue reservoirs in maximally suppressed individuals. J Acquir Immune Defic Syndr. 2006;43(1):65-68.